Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black women

Purpose: Human papillomavirus (HPV) is the causative agent of cervical cancer. Black women are disproportionally diagnosed and have higher mortality from cervical cancer in the United States. Here we describe the prophylactic efficacy and safety of a quadrivalent HPV-6/11/16/18 vaccine in black wome...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2013

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/22218

Acceso en línea:

https://doi.org/10.1016/j.jadohealth.2012.07.003
https://repository.urosario.edu.co/handle/10336/22218

Palabra clave:

Placebo
Wart virus vaccine
Adult
Article
Chlamydiasis
Clinical trial
Condyloma acuminatum
Dna virus
Drug efficacy
Drug safety
Drug withdrawal
Ethnicity
Female
Fetus death
Fetus wastage
Human
Infection prevention
Live birth
Major clinical study
Medical history
Papillomavirus infection
Pregnancy outcome
Priority journal
Side effect
Spontaneous abortion
Uterine cervix carcinoma in situ
Vaginal intraepithelial neoplasia
Adolescent
African americans
African continental ancestry group
Alphapapillomavirus
Chlamydia infections
Chlamydia trachomatis
Female
Human papillomavirus 11
Humans
Papilloma
Papillomavirus infections
Papillomavirus vaccines
United states
Young adult
Cervical cancer
Human papillomavirus
Prophylactic efficacy
Vaccine

Rights

License

Abierto (Texto Completo)